CD4+ T-lymphocytopenia in long-term survivors following intensive chemotherapy in childhood cancers

Medical and Pediatric Oncology

Volumn 30, Issue 1, 1998, Pages 40-45

  Azuma, Eiichi ^a   Nagai, Masataka ^a   Qi, Jiang ^a   Umemoto, Masakazu ^a   Hirayama, Masahiro ^a   Kumamoto, Tadashi ^a   Hiratake, Shinya ^a   Komada, Yoshihiro ^a   Sakurai, Minoru ^a  

^a MIE UNIVERSITY   (Japan)

Author keywords

CD4+ T lymphocytopenia; Childhood cancers; Long term survivors

Indexed keywords

ANTINEOPLASTIC AGENT;

ADOLESCENT; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER REGRESSION; CANCER SURVIVAL; CHILD; CHILDHOOD CANCER; FEMALE; FLOW CYTOMETRY; FOLLOW UP; HUMAN; LONG TERM CARE; LYMPHOCYTE FUNCTION; LYMPHOCYTOPENIA; MAJOR CLINICAL STUDY; MALE; NATURAL KILLER CELL; PRIORITY JOURNAL; SURVIVAL TIME; T LYMPHOCYTE;

EID: 0030671547     PISSN: 00981532     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1096-911X(199801)30:1<40::AID-MPO11>3.0.CO;2-C     Document Type: Article

References (16)

1. Soriano V, Hewlett I, Heredia A, et al.: Idiopatic CD4+ T-lymphocytopenia. Lancet 340:607-608, 1992.
2. Brunvand MW, Collins C, Livingston RB, et al.: Pneumocystis carinii pneumonia associated with profound lymphopenia and abnormal T-lymphocyte subset ratios during treatment for early-stage breast carcinoma. Cancer 67:2407-2410, 1991.
3. Mackall CL, Granger L, Sheard MA, et al.: T-cell regeneration after bone marrow transplantation: Differential CD45 isoform expression on thymic-derived versus thymic-independent progeny. Blood 82:2585-2594, 1993.
4. + T-lymphocyte regeneration after intensive chemotherapy. New Engl J Med 332:143-149, 1995.
5. Azuma E, Masuda S, Hanada M, et al.: Hyperimmunoglobulinemia D following cancer chemotherapy. Oncology 48:387-91, 1991.
6. Bennett JM, Catovshy D, Daiel MT, et al: Proposals for the classification of the acute leukemias. Br J Haematol 33:451-458, 1976.
7. Komada Y, Azuma E, Sakurai M, et al.: Discontinuing chemoimmunotherapy in childhood acute lymphoblastic leukemia treated with a chemotherapy protocol. Cancer Immunol. Immunother 29: 51-56, 1989.
8. Azuma E, Umemoto M, Sakurai M, et al.: CD34 expression in children with Philadelphia chromosome-positive acute lymphoblastic leukemia. Cancer 67:1565-1569, 1991.
9. Busch MP, Valinsky JE, Paglieroni T, et al.: Screening of blood donors for idiopathic CD4+ T-lymphocytopenia. Transfusion 34: 192-197, 1994.
10. Cao Y, Qin L, Zhang L, et al.: Virologic and immunologic characterization of long-term survivors of human immunodeficiency virus type 1 infection. New Engl J Med 332:201-208, 1995.
11. Bryd R: Late effects of treatment of cancer children. Pediatr Clin North Am 32:835-857, 1985.
12. McVay LD, Carding SR: Extrathymic origin of human gd T cells during fetal development. J Immunol 157:2873-2882, 1996.
13. Modlin RL, Pirmez C, Hofman FM, et al.: Lymphocytes bearing antigen-specific gd T-cell receptors accumulate in human infectious disease lesions. Nature 339:544-548, 1989.
14. Hara T, Mizuno Y, Takaki K, et al.: Predominant activation and expansion of Vg9-bearing gd T cells in vivo as well as in vitro in Salmonella infection. J Clin Invest 90:204-210, 1992.
15. Walters MC, Abelson HT: Interpretation of the complete blood count. Pediatr Clin North Am 43:599-622, 1996.
16. Pacheco SE, Shearer WT: Laboratory aspects of immunology. Pediatr Clin North Am 41:623-655, 1994.